Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DME91CG)

Drug Name

Lerdelimumab Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Transforming growth factor beta 2 (TGFB2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
AP12009	DMUYOC8	Colorectal cancer	2B91.Z	Phase 3	[2]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Transforming growth factor beta 2 (TGFB2)	TTY9TWO	TGFB2_HUMAN	Not Available	[1]

------------------------------------------------------------------------------------

References

1	A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy. Ophthalmology. 2007 Oct;114(10):1822-30.
2	Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.